Christine Guertin

Christine Guertin has extensive experience in regulatory affairs, starting in 1999 at Genzyme as a Regulatory Affairs Information Coordinator II. Christine then worked as a Regulatory Affairs Associate II at DUSA Pharmaceuticals, Inc. from 2005 to 2007. Guertin joined Takeda Pharmaceuticals in 2007 as an Associate Director of Regulatory Affairs, where they worked until 2016. From 2016 to 2018, they served as the Director of Regulatory Affairs at Array BioPharma Inc. Following this, they held the position of Head of Regulatory Affairs at Synlogic, Inc. from 2018 to 2019. Most recently, Guertin worked as the Vice President of Regulatory Affairs and Quality Assurance at Curis from 2019 to 2023. Christine is currently the Vice President of Regulatory Affairs at Taiho Oncology, Inc., starting in April 2023.

Christine Guertin completed their Master of Science (MS) degree in Health Product Regulation from Regis College, which they attended from 2004 to 2006. Prior to that, they earned their Bachelor of Arts (BA) degree in Mathematics from Saint Joseph's College, where they studied from 1993 to 1997. Christine completed their secondary education at Wakefield High School, although no specific dates or degrees were provided for this.